Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression

American Journal of Clinical Pathology

Volumn 138, Issue 1, 2012, Pages 132-139

  Gradowski, Joel F ^a   Sargent, Rachel L ^a   Craig, Fiona E ^a   Cieply, Kathleen ^a   Fuhrer, Kim ^a   Sherer, Carol ^a   Swerdlow, Steven H ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic lymphocytic leukemia; Cyclin d1; Proliferation centers; Small lymphocytic lymphoma; SOX11

Indexed keywords

CD23 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; TRANSCRIPTION FACTOR SOX11;

ADULT; AGED; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETIC GAIN; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLAST; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTOMA; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; TUMOR BIOPSY;

AGED; AGED, 80 AND OVER; CYCLIN D1; FEMALE; GERMINAL CENTER; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; SOXC TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 84864225880     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPIVKZRMPF93ET     Document Type: Article

References (51)

1. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008.
2. Müller-Hermelink HK, Montserrat E, Catovsky D, et al. Chronic lymphocytic leukaemia/small lymphocytic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008:180-182.
3. Swerdlow SH, Campo E, Seto M, et al. Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008:229-232.
4. Lampert IA, Wotherspoon A, Van Noorden S, et al. High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen. Hum Pathol. 1999;30:648-654. (Pubitemid 29266723)
5. Soma LA, Craig FE, Swerdlow SH. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol. 2006;37:152-159. (Pubitemid 43099834)
6. Bertilaccio MT, Scielzo C, Muzio M, et al. An overview of chronic lymphocytic leukaemia biology. Best Pract Res Clin Haematol. 2010;23:21-32.
7. Caligaris-Cappio F, Chiorazzi N. Where is the biology of CLL leading us? Semin Cancer Biol. 2010;20:361-362.
8. Zenz T, Mertens D, Kuppers R, et al. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer. 2010;10:37-50.
9. Klein U, Dalla-Favera R. New insights into the pathogenesis of chronic lymphocytic leukemia. Semin Cancer Biol. 2010;20:377-383.
10. Bonato M, Pittaluga S, Tierens A, et al. Lymph node histology in typical and atypical chronic lymphocytic leukemia. Am J Surg Pathol. 1998;22:49-56. (Pubitemid 28016751)
11. Giné E, Martinez A, Villamor N, et al. Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica. 2010;95:1526-1533.
12. Swerdlow SH, Zukerberg LR, Yang WI, et al. The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements. Am J Surg Pathol. 1996;20:627-640. (Pubitemid 26129450)
13. Orchard J, Garand R, Davis Z, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood. 2003;101:4975-4981. (Pubitemid 36857762)
14. Kelemen K, Peterson LC, Helenowski I, et al. CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with CD23- disease. Am J Clin Pathol. 2008;130:166-177.
15. Gao J, Peterson L, Nelson B, et al. Immunophenotypic variations in mantle cell lymphoma. Am J Clin Pathol. 2009;132:699-706.
16. Bahler DW, Aguilera NS, Chen CC, et al. Histological and immunoglobulin VH gene analysis of interfollicular small lymphocytic lymphoma provides evidence for two types. Am J Pathol. 2000;157:1063-1070.
17. Gibson SE, Swerdlow SH, Ferry JA, et al. Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica. 2011;96:1148-1152.
18. Habib LK, Finn WG. Unsupervised immunophenotypic profiling of chronic lymphocytic leukemia. Cytometry B Clin Cytom. 2006;70:124-135.
19. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-330.
20. Hunter T, Pines J. Cyclins and cancer: II, cyclin D and CDK inhibitors come of age. Cell. 1994;79:573-582. (Pubitemid 24363801)
21. Sherr CJ. Cancer cell cycles. Science. 1996;274:1672-1677.
22. Williams ME, Swerdlow SH, Rosenberg CL, et al. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia. 1993;7:241-245. (Pubitemid 23079234)
23. Williams ME, Westermann CD, Swerdlow SH. Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus. Blood. 1990;76:1387-1391. (Pubitemid 20342756)
24. Hoyer JD, Hanson CA, Fonseca R, et al. The (11;14) (q13;q32) translocation in multiple myeloma: a morphologic and immunohistochemical study. Am J Clin Pathol. 2000;113:831-837. (Pubitemid 33051519)
25. Cook JR, Hsi ED, Worley S, et al. Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival. Am J Clin Pathol. 2006;125:615-624.
26. Chen D, Ketterling RP, Hanson CA, et al. A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited. Am J Surg Pathol. 2011;35:1080-1084.
27. Chen YH, Gao J, Fan G, Peterson LC. Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms. Mod Pathol. 2010;23:105-112.
28. Cheuk W, Wong KO, Wong CS, et al. Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody. Am J Surg Pathol. 2004;28:801-807. (Pubitemid 38685895)
29. Abboudi Z, Patel K, Naresh KN. Cyclin D1 expression in typical chronic lymphocytic leukaemia. Eur J Haematol. 2009;83:203-207.
30. O'Malley DP, Vance GH, Orazi A. Chronic lymphocytic leukemia/small lymphocytic lymphoma with trisomy 12 and focal cyclin D1 expression: a potential diagnostic pitfall. Arch Pathol Lab Med. 2005;129:92-95. (Pubitemid 40094036)
31. Sola B, Roue G, Duquesne F, et al. Expression of cyclins D-type in B-chronic lymphoproliferative disorders. Leukemia. 2000;14:1318-1319. (Pubitemid 30445043)
32. Yang WI, Zukerberg LR, Motokura T, et al. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol. 1994;145:86-96. (Pubitemid 24217487)
33. Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8:1640-1645. (Pubitemid 24323778)
34. Swerdlow SH, Habeshaw JA, Murray LJ, et al. Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity - a multiparameter study of 18 cases at diagnosis and relapse. Am J Pathol. 1983;113:181-197. (Pubitemid 13023454)
35. Bosch F, Campo E, Jares P, et al. Increased expression of the PRAD-1/CCND1 gene in hairy cell leukaemia. Br J Haematol. 1995;91:1025-1030.
36. Balogh Z, Reiniger L, Rajnai H, et al. High rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia. Leuk Lymphoma. 2011;52:1080-1084.
37. Ellison DJ, Nathwani BN, Cho SY, et al. Interfollicular small lymphocytic lymphoma: the diagnostic significance of pseudofollicles. Hum Pathol. 1989;20:1108-1118. (Pubitemid 19275379)
38. Fend F, Quintanilla-Martinez L, Kumar S, et al. Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas: a molecular analysis using laser capture microdissection. Am J Pathol. 1999;154:1857-1866. (Pubitemid 29262869)
39. Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117:5019-5032.
40. Nodit L, Bahler DW, Jacobs SA, et al. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol. 2003;34:1030-1034. (Pubitemid 37315255)
41. Dictor M, Ek S, Sundberg M, et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica. 2009;94:1563-1568.
42. Mozos A, Royo C, Hartmann E, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009;94:1555-1562.
43. Fernandez V, Salamero O, Espinet B, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010;70:1408-1418.
44. Malavasi F, Deaglio S, Damle R, et al. CD38 and chronic lymphocytic leukemia: a decade later. Blood. 2011;118:3470-3478.
45. Falini B, Fizzotti M, Pucciarini A, et al. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood. 2000;95:2084-2092. (Pubitemid 30151649)
46. Granziero L, Ghia P, Circosta P, et al. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood. 2001;97:2777-2783.
47. Stein H, Bonk A, Tolksdorf G, et al. Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas. J Histochem Cytochem. 1980;28:746-760.
48. Swerdlow SH, Murray LJ, Habeshaw JA, et al. Lymphocytic lymphoma/B-chronic lymphocytic leukaemia: an immunohistopathological study of peripheral B lymphocyte neoplasia. Br J Cancer. 1984;50:587-599. (Pubitemid 15211628)
49. Tsuboi K, Iida S, Inagaki H, et al. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia. 2000;14:449-456. (Pubitemid 30142870)
50. Damle RN, Temburni S, Calissano C, et al. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood. 2007;110:3352-3359. (Pubitemid 350106329)
51. Patten PE, Buggins AG, Richards J, et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood. 2008;111:5173-5181.